{"id":"https://openalex.org/W2011065486","doi":"https://doi.org/10.7326/0003-4819-117-6-457","title":"In-Vitro Resistance to Zidovudine and Alpha-interferon in HIV-1 Isolates from Patients: Correlations with Treatment Duration and Response","display_name":"In-Vitro Resistance to Zidovudine and Alpha-interferon in HIV-1 Isolates from Patients: Correlations with Treatment Duration and Response","alternate_titles":[],"publication_year":1992,"publication_date":"1992-09-15","ids":{"openalex":"https://openalex.org/W2011065486","doi":"https://doi.org/10.7326/0003-4819-117-6-457","mag":"2011065486","pmid":"https://pubmed.ncbi.nlm.nih.gov/1503348"},"language":"en","primary_location":{"id":"doi:10.7326/0003-4819-117-6-457","doi":"https://doi.org/10.7326/0003-4819-117-6-457","is_oa":false,"landing_page_url":"https://doi.org/10.7326/0003-4819-117-6-457","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011065486"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058766272","display_name":"Brian R. Edlin","orcid":"https://orcid.org/0000-0001-8172-8797","observed_orcids":["https://orcid.org/0000-0001-8172-8797"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brian R. Edlin","raw_affiliation_strings":["Division of HIV/AIDS, Centers for Disease Control, Atlanta, GA 30333"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of HIV/AIDS, Centers for Disease Control, Atlanta, GA 30333","institution_ids":["https://openalex.org/I1289490764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072376702","display_name":"M H St Clair","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marty H. St. Clair","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108432024","display_name":"Paula M. Pitha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P.M. Pitha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047412983","display_name":"Susan M. Whaling","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susan M. Whaling","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Diane M. King","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Diane M. King","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045382891","display_name":"Jacob David Bitran","orcid":"https://orcid.org/0009-0008-8167-1928","observed_orcids":["https://orcid.org/0009-0008-8167-1928"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacob D. Bitran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5026024349","display_name":"Robert A. Weinstein","orcid":"https://orcid.org/0000-0002-3390-858X","observed_orcids":["https://orcid.org/0000-0002-3390-858X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert A. Weinstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.5517,"has_fulltext":false,"cited_by_count":39,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94404968,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"117","issue":"6","first_page":"457","last_page":"460"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.011599999852478504,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.8679999709129333},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.847000002861023},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9670000076293945},{"id":"https://openalex.org/keywords/antiviral-resistance","display_name":"antiviral resistance","score":0.8870000243186951},{"id":"https://openalex.org/keywords/interferon-resistance","display_name":"interferon resistance","score":0.7490000128746033},{"id":"https://openalex.org/keywords/in-vitro-susceptibility","display_name":"in vitro susceptibility","score":0.6840000152587891},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.7289999723434448},{"id":"https://openalex.org/keywords/aids","display_name":"AIDS","score":0.625},{"id":"https://openalex.org/keywords/p24-antigen","display_name":"p24 antigen","score":0.722000002861023},{"id":"https://openalex.org/keywords/endogenous-interferon","display_name":"endogenous interferon","score":0.8130000233650208},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.8399999737739563},{"id":"https://openalex.org/keywords/interferon-therapy-response","display_name":"interferon therapy response","score":0.3409999907016754},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.4429999887943268},{"id":"https://openalex.org/keywords/disease-stage","display_name":"disease stage","score":0.4300000071525574},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.3440000116825104}],"concepts":[{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.9431281089782715},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8475812077522278},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.641116738319397},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.575961172580719},{"id":"https://openalex.org/C35785553","wikidata":"https://www.wikidata.org/wiki/Q756720","display_name":"Ambulatory","level":2,"score":0.5091316103935242},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.480881005525589},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44207191467285156},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.43525582551956177},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.43468883633613586},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4135867953300476},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.38041025400161743},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3721305727958679},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3588946461677551},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34302210807800293},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.28351184725761414}],"mesh":[{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D004352","descriptor_name":"Drug Resistance, Microbial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.7326/0003-4819-117-6-457","doi":"https://doi.org/10.7326/0003-4819-117-6-457","is_oa":false,"landing_page_url":"https://doi.org/10.7326/0003-4819-117-6-457","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},{"id":"pmid:1503348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1503348","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of internal medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W76273905","https://openalex.org/W1521635132","https://openalex.org/W1523814949","https://openalex.org/W1899816681","https://openalex.org/W1973013569","https://openalex.org/W2010761190","https://openalex.org/W2028143521","https://openalex.org/W2028362497","https://openalex.org/W2035166969","https://openalex.org/W2057054797","https://openalex.org/W2057501205","https://openalex.org/W2075734641","https://openalex.org/W2077468566","https://openalex.org/W2079501165","https://openalex.org/W2086462809","https://openalex.org/W2086470623","https://openalex.org/W2088255505","https://openalex.org/W2096106220","https://openalex.org/W2106603936","https://openalex.org/W2116696460","https://openalex.org/W2162154973","https://openalex.org/W2166803199","https://openalex.org/W2327527388","https://openalex.org/W4317563663"],"related_works":["https://openalex.org/W2044995509","https://openalex.org/W2074284686","https://openalex.org/W2417331186","https://openalex.org/W2166803199","https://openalex.org/W2132709701","https://openalex.org/W2396610918","https://openalex.org/W2162154973","https://openalex.org/W2106603936","https://openalex.org/W1968370721","https://openalex.org/W4299860750"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"measure":[2],"in-vitro":[3],"antiviral":[4],"drug":[5],"susceptibilities":[6],"of":[7,35,41,63,85,98,113,147,170,231,254,292,300,304],"human":[8],"immunodeficiency":[9,204],"virus":[10],"type":[11],"1":[12],"(HIV-1)":[13],"isolates":[14,106,180,196,272],"recovered":[15,107],"from":[16,108,181,197,213,229,314],"patients":[17,24,65,78,120,182,200,216,233,241,247,260,309],"treated":[18,26],"with":[19,27,88,145,201,242,269],"alpha-interferon":[20,48,68,101,129,158,171,188,192,263],"or":[21],"zidovudine":[22,89,99,133,148],"and":[23,30,45,70,90,100,234],"not":[25,166,288],"these":[28,36,64],"drugs":[29],"to":[31,39,47,132,140,162,168,191,284,290,312],"examine":[32],"the":[33,118,122,198,202,214,298],"relation":[34],"susceptibility":[37,306],"measurements":[38],"duration":[40,146,169,291],"therapy,":[42,69],"disease":[43],"stage,":[44],"response":[46],"therapy.":[49,76,189,302],"DESIGN:":[50],"Cross-sectional":[51],"study.":[52],"SETTING:":[53],"Outpatient":[54],"HIV":[55],"clinic.":[56],"PATIENTS:":[57],"Twenty-six":[58],"ambulatory":[59],"HIV-1-infected":[60],"patients:":[61],"Fifteen":[62],"were":[66,79,125,177,265],"receiving":[67],"11":[71],"had":[72,184],"never":[73,185],"received":[74,186],"such":[75],"Nine":[77],"participating":[80],"in":[81,117,121,173,179,195,211,226,240,245,251,258,267],"a":[82],"clinical":[83,123],"trial":[84,124],"combination":[86],"therapy":[87,149,264,294],"alpha-interferon.":[91],"MEASUREMENTS:":[92],"The":[93],"50%":[94],"inhibitory":[95],"concentration":[96],"(IC50)":[97],"was":[102,130,165,193,224,235],"determined":[103],"for":[104],"HIV-1":[105,114,255],"each":[109],"patient.":[110],"Plasma":[111],"concentrations":[112,253],"p24":[115,256],"antigen":[116,257],"nine":[119,259],"measured":[126],"monthly":[127],"after":[128,261],"added":[131],"monotherapy.":[134],"RESULTS:":[135],"Zidovudine":[136],"IC50":[137,159],"(range,":[138,160],"0.01":[139],"4.87":[141],"microM)":[142],"increased":[143],"steadily":[144],"(r":[150,273],"=":[151,154,274,277],"0.57,":[152],"P":[153,276],"0.003).":[155],"In":[156],"contrast,":[157],"0.8":[161],"415":[163],"units/mL)":[164,209],"related":[167,289],"treatment;":[172],"fact,":[174],"high":[175],"IC50s":[176],"found":[178],"who":[183],"exogenous":[187],"Resistance":[190],"greater":[194,266],"15":[199],"acquired":[203],"syndrome":[205],"(AIDS)":[206],"(median,":[207,219],"104":[208],"than":[210,244],"those":[212,268],"10":[215],"without":[217,248],"AIDS":[218,243],"50":[220],"units/mL).":[221],"Interferson":[222],"activity":[223],"detected":[225],"plasma":[227,252],"samples":[228],"23":[230],"24":[232],"also":[236],"at":[237],"higher":[238],"levels":[239],"HIV-infected":[246],"AIDS.":[249],"Reductions":[250],"beginning":[262],"more":[270],"susceptible":[271],"-0.72,":[275],"0.03).":[278],"CONCLUSIONS:":[279],"Interferon":[280],"resistance,":[281],"possibly":[282],"due":[283],"endogenous":[285],"interferon,":[286],"is":[287],"interferon":[293,301,305],"but":[295],"may":[296,307],"limit":[297],"effectiveness":[299],"Determinations":[303],"identify":[308],"most":[310],"likely":[311],"benefit":[313],"this":[315],"agent.":[316]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2011065486","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
